Semi-Annual Statement Of Cash Flows

Immuno-Biological Laboratories Co., Ltd. - Filing #7597262

Concept 2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
As at
2020-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-84,173,000 JPY
-190,956,000 JPY
Interest and dividends received
125,000 JPY
153,000 JPY
Interest paid
-730,000 JPY
-836,000 JPY
Income taxes paid
-8,425,000 JPY
-2,504,000 JPY
Net cash provided by (used in) operating activities
-93,204,000 JPY
-194,145,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
JPY
-13,460,000 JPY
Proceeds from sale of property, plant and equipment
371,000 JPY
JPY
Loan advances
-10,000,000 JPY
JPY
Other, net
JPY
30,000 JPY
Net cash provided by (used in) investing activities
-155,629,000 JPY
-17,233,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
60,000,000 JPY
50,000,000 JPY
Repayments of long-term borrowings
-21,002,000 JPY
-66,000,000 JPY
Net cash provided by (used in) financing activities
143,998,000 JPY
-216,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
1,998,000 JPY
4,944,000 JPY
Net increase (decrease) in cash and cash equivalents
-102,837,000 JPY
-422,434,000 JPY
Cash and cash equivalents
449,184,000 JPY
552,022,000 JPY
974,456,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.